Making pharma manufacturing more efficient with data-based evidence and digital tools

Hi! We're CIM.AS! When you reach the bottom of this page, you'll know why we're so set on ridding pharma of the manual processes and paper stacks that are weighing it down - and why we think we're the best at doing that.

Pharma deserves better tools

Patient safety is at the heart of pharma. But the GxP processes that ensure this are complex and time-consuming. They create tension between production and QA teams. And they disrupt production plans.

In fact, 30% of staff time is spent on documentation-related activities and the biggest delay in batch releases is related to the QA function.

Legacy systems not built for the digital age force production and QA teams to spend their time on manual documentation and chasing information across endless systems and files. All while they miss output targets and live in a constant fear of making mistakes.

That's what we're here to change.

Our domains

Software products for key areas of pharma production

icon-product-page-video-analysis
Machine Vision
Pre-validated, configurable vision platform powered by machine learning and deep learning.
icon-product-page-pharma40
Digital Compliance
Audit-ready pharmaceutical manufacturing without manual logging and endless PDFs
icon-product-page-asset-monitoring
Data Insights
Connectivity, data collection, storage, visualization, and decision support - all in a GxP-validated platform
Our customers

We partner with pharma's finest

Our customers come from a wide range of areas. But with decades of pharma experience, we are the ideal partner for:

  • Pharma companies who want remove QA-related delays with audit-ready and automatically logged data.
  • Medical device manufacturers who want to automate quality testing in production or R&D and meet growing compliance demands.
  • OEMs who want to meet pharma's IT and compliance demands without risking their margins and their sanity.
Certifications

We meet pharma's standards

Our quality and environmental management system is certified by Bureau Veritas according to ISO 9001 and 14001 and in 2025 we also achieved the ISO 27001 certification — the internationally recognized standard for information security management systems (ISMS).

The QEMS integrates best practices for project execution and environmental responsibility and allows us to standardize our processes and improve performance over time.

Here's what sustainability means to us

Having a bigger purpose

We want our products to contribute to access to medicine and less strain on planetary resources.

Taking action every day

Our ISO 14001 certification ensures that we consider the impact of everything we do and keep working towards improving. Our offices run on 100% green electricity (and have done so since 2020) and 70% renewable heating.

In 2025 we were awarded an EcoVadis Gold medal, putting us in the top 5%.

Ownership

CIM.AS - part of something bigger

CIM joined XANO Industri A/B in 2021.

XANO makes long-term investments in unique companies with growth potential, and we're grateful to be backed by such a strong owner.

About XANO:

  • Listed on the Nasdaq Stockholm Stock Exchange
  • Global presence across Europe, Americas & Asia
  • 2022 revenue of MSEK 3,509 (app. MEUR 350)
  • 1450 employees
Our history

25 years of digitalizing manufacturing

  • 1998: Software engineers Niels Sørensen, Ole Thomsen and Allan Henneberg found CIM Industrial Systems A/S, drawing on their experience with  software, data collection and test solutions from Bang & Olufsen and Grundfos.
  • 2000: Per Clausen joins the group and founds CIM Electronics A/S.
  • 2011: CIM acquires the machine vision division from T&O Stelectric A/S. CIM Vision Lab opens in Aarhus. Pharma becomes the main strategic focus.
  • 2012: Acquisition of Sequanto A/S, including its visual software testing tool, SeqZap.
  • 2017: Michel Seidelin joins as CEO and the two companies CIM Electronics and CIM Industrial Systems become CIM.AS.
  • 2020: Launch of CATCH.AI - an open IoT platform for production environments.
  • 2023: The inaugural REIMAGINE PHARMA event takes place, bringing together pharma MSAT, QA and production professionals.
mse
svg

Do you want to know more about CIM?

Contact CEO Michel Seidelin for more information